Arbutus Biopharma Corp ( ABUS) - Key Metrics
ABUS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q3 | $0 | $0.30 | $1.21 | $1.21 |
| 2026Q2 | $0.01 | -$0.03 | -$0.03 | -$0.03 |
| 2026Q1 | $0.92 | $0.88 | -$0.04 | -$0.04 |
| 2025Q4 | $0.01 | -$0.02 | -$0.02 | -$0.02 |
| 2025Q3 | $0 | -$0.04 | -$0.03 | -$0.03 |
ABUS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q3 | 0% | 3.98 |
| 2026Q2 | 0% | -40 |
| 2026Q1 | 0% | 1.28 |
| 2025Q4 | 0% | -61.67 |
| 2025Q3 | 0% | -28.38 |
ABUS Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q3 | 25.25% | 0% |
| 2026Q2 | -0.63% | 0% |
| 2026Q1 | -0.93% | 0% |
| 2025Q4 | -0.51% | 0% |
| 2025Q3 | -0.67% | 0% |
ABUS
Price: $4.08
52 week price:
Payout Ratio Range:
Earnings Per Share: 1.12 USD
P/E Ratio: 3.46
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 545700
Ebitda: -10.9 millionMarket Capitalization: 594.8 million